Kevin Haas

Kevin Haas is a seasoned finance professional with extensive experience in various leadership roles within the pharmaceutical and biotechnology sectors. Currently serving as Controller at Vincerx Pharma since December 2020, Kevin previously held multiple positions at Aravive, Inc., including Consultant and VP Finance, where Kevin was instrumental in managing the finance function during a significant reverse merger. Prior roles include Corporate Controller at Versartis, Inc., where Kevin led the company through an IPO, and Director of SEC Reporting, Compliance & FP&A at InterMune, Inc., contributing to the company's $7 billion acquisition by Roche. Kevin began a successful career at Cisco Systems, Inc., progressing through roles in financial management and reporting. Kevin holds a Bachelor's degree in Business/Accounting from Western Colorado University.